These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3461712)

  • 21. Philadelphia chromosome and TdT-positive AML.
    Brusamolino E; Isernia P; Bernasconi C; Bertazzoni U
    J Clin Oncol; 1984 Aug; 2(8):970-1. PubMed ID: 6589365
    [No Abstract]   [Full Text] [Related]  

  • 22. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
    Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The importance of terminal deoxyribonucleotidyl transferase in myeloblastic leukemias. Apropos of 2 cases].
    San Miguel JF; Portero JA; Gonzaĺez M; Plaza JP; Caballero MD; De Cecilia A; Fernández JJ; López Borrasca A
    Sangre (Barc); 1983; 28(6):746-52. PubMed ID: 6585006
    [No Abstract]   [Full Text] [Related]  

  • 24. Reactivity patterns of monoclonal antibodies positive on myelomonocytic leukemia cells as defined by esterase isoenzyme analysis.
    Drexler HG; Menon M; Gaedicke G; Minowada J
    Cancer Immunol Immunother; 1986; 21(3):188-92. PubMed ID: 3457629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxyribonucleotidyltransferase.
    Seremetis SV; Pelicci PG; Tabilio A; Ubriaco A; Grignani F; Cuttner J; Winchester RJ; Knowles DM; Dalla-Favera R
    J Exp Med; 1987 Jun; 165(6):1703-12. PubMed ID: 3473183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of TdT positivity in cases of leukemia and lymphoma.
    Drexler HG; Menon M; Minowada J
    Acta Haematol; 1986; 75(1):12-7. PubMed ID: 3088880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of myeloid leukemias with monoclonal antibodies 3C5 and MY9.
    Matutes E; Rodriguez B; Polli N; Tavares de Castro J; Parreira A; Andrews C; Griffin JD; Tindle RW; Catovsky D
    Hematol Oncol; 1985; 3(3):179-86. PubMed ID: 3862640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity.
    Robertson PB; Neiman RS; Worapongpaiboon S; John K; Orazi A
    Mod Pathol; 1997 Apr; 10(4):277-82. PubMed ID: 9110287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of terminal deoxynucleotidyl transferase (TdT) in nonlymphocytic leukemia by immunofluorescent (IF) assay.
    Sasaki R; Miura Y
    Leukemia; 1995 Mar; 9(3):520-1. PubMed ID: 7885053
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of terminal deoxynucleotidyl transferase in the diagnosis of leukemia.
    Morse EE; Gaffney J; Donskoy E; Pisciotto P; Altman A; Quinn J; Goldschneider I
    Ann Clin Lab Sci; 1983; 13(2):128-32. PubMed ID: 6344744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
    Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute nonmyeloid leukemia in adults. Study of membrane antigens and terminal transferase. Diagnostic and prognostic value].
    Ifrah N; Perrot JY; Marie JP; Rio B; Julien C; Cadiou M; Boucheix C; Zittoun R
    Presse Med; 1985 Jan; 14(3):137-41. PubMed ID: 3156336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of terminal transferase activity and glucocorticoid receptor levels in acute myeloid leukemia.
    Skoog L; Ost A; Biberfeld P; Christensson B; Hast R; Lagerlöf B; Nordenskjöld B; Reizenstein P
    Br J Cancer; 1984 Oct; 50(4):443-9. PubMed ID: 6593093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proposed criteria for classification of acute myeloid leukemia in dogs and cats.
    Jain NC; Blue JT; Grindem CB; Harvey JW; Kociba GJ; Krehbiel JD; Latimer KS; Raskin RE; Thrall MA; Zinkl JG
    Vet Clin Pathol; 1991; 20(3):63-82. PubMed ID: 12673541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of detecting surface and cytoplasmic antigens in acute myeloid leukaemia.
    Urbano-Ispizua A; Matutes E; Villamor N; Sierra J; Pujades A; Reverter JC; Feliu E; Cervantes F; Vives-Corrons JL; Montserrat E
    Br J Haematol; 1992 Jun; 81(2):178-83. PubMed ID: 1322689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous or sequential expression of lymphoid and myeloid phenotypes in acute leukemia.
    Neame PB; Soamboonsrup P; Browman G; Barr RD; Saeed N; Chan B; Pai M; Benger A; Wilson WE; Walker IR
    Blood; 1985 Jan; 65(1):142-8. PubMed ID: 3880643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Terminal deoxynucleotidyl transferase and CD7 expression in acute myeloid leukemias are not associated with a high frequency of immunoglobulin and/or T cell receptor gene rearrangement.
    Willière G; Stockinger H; Köller U; Majdic O; Schnabl E; Lutz D; Bettelheim P; Knapp W
    Leukemia; 1990 Apr; 4(4):278-81. PubMed ID: 1694941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactivity pattern of 'myeloid monoclonal antibodies' with emphasis on MCS-2.
    Drexler HG; Sagawa K; Menon M; Minowada J
    Leuk Res; 1986; 10(1):17-23. PubMed ID: 3456072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rearrangements of immunoglobulin and T cell receptor beta and gamma genes are associated with terminal deoxynucleotidyl transferase expression in acute myeloid leukemia.
    Foa R; Casorati G; Giubellino MC; Basso G; Schirò R; Pizzolo G; Lauria F; Lefranc MP; Rabbitts TH; Migone N
    J Exp Med; 1987 Mar; 165(3):879-90. PubMed ID: 3102679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Translocation (6;9) may be associated with a specific TdT-positive immunological phenotype in ANLL.
    Adriaansen HJ; van Dongen JJ; Hooijkaas H; Hählen K; van 't Veer MB; Löwenberg B; Hagemeijer A
    Leukemia; 1988 Mar; 2(3):136-40. PubMed ID: 3347092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.